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Abstract
Introduction Large-tidal volume (VT) mechanical ventilation and
hyperoxia used in patients with acute respiratory distress
syndrome can damage pulmonary epithelial cells through lung
inflammation and apoptotic cell death. Hyperoxia has been
shown to increase ventilator-induced lung injury, but the
mechanisms regulating interaction between large VT  and
hyperoxia are unclear. We hypothesized that the addition of
hyperoxia to large-VT  ventilation would increase neutrophil
infiltration by upregulation of the cytokine macrophage
inflammatory protein-2 (MIP-2) and would increase apoptosis
via the mitogen-activated protein kinase pathways.
Methods C57BL/6 mice were exposed to high-VT (30 ml/kg)
mechanical ventilation with room air or hyperoxia for one to five
hours.
Results The addition of hyperoxia to high-VT  ventilation
augmented lung injury, as demonstrated by increased apoptotic
cell death, neutrophil migration into the lung, MIP-2 production,
MIP-2 mRNA expression, increased DNA binding activity of
activator protein-1, increased microvascular permeability, and c-
Jun NH2-terminal kinase (JNK) and extracellular signal-regulated
kinase (ERK) 1/2 activation. Hyperoxia-induced augmentation of
high-VT-induced lung injury was attenuated in JNK-deficient
mice and in mice with pharmacologic inhibition of ERK activity
by PD98059. However, only JNK-deficient mice, and not mice
with ERK activity inhibition by PD98059, were protected from
high-VT-induced lung injury without hyperoxia.
Conclusion We conclude that hyperoxia increased high-VT-
induced cytokine production, neutrophil influx, and apoptotic
cell death through activation of the JNK and ERK1/2 pathways.
Introduction
Acute respiratory distress syndrome (ARDS) is an inhomoge-
neous lung disease characterized by non-cardiogenic pulmo-
nary edema, release of cytokines, and influx of neutrophils and
requires the use of mechanical ventilation with high levels of
oxygen to adequately oxygenate the brain and other vital
organs [1-14]. However, mechanical ventilation and pro-
longed exposure to hyperoxia can damage pulmonary epithe-
lial cells through either apoptotic or non-apoptotic cell death
[1-10]. Mechanical ventilation with high tidal volume (VT) val-
ues causes acute lung injury (ventilator-induced lung injury
[VILI]) characterized by an inflammatory response that is simi-
AP-1 = activator protein-1; ARDS = acute respiratory distress syndrome; BAL = bronchoalveolar lavage; DAB = diaminobenzidine; DIG = digoxi-
genin; EBD = Evans blue dye; EMSA = electrophoretic mobility shift assay; ERK = extracellular signal-regulated kinase; IL = interleukin; JNK = c-Jun 
NH2-terminal kinase; MAPK = mitogen-activated protein kinase; MIP-2 = macrophage inflammatory protein-2; MPO = myeloperoxidase; NF-κB = 
nuclear factor-kappa-B; NIH = National Institutes of Health; PARP = poly(ADP-ribose)polymerase; TMB = 3,3', 5,5'-tetramethylbenzidine; TUNEL = 
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling; VILI = ventilator-induced lung injury; VT = tidal volume.Critical Care    Vol 11 No 1    Li et al.
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lar to that caused by bacterial lipopolysaccharide [11,12] and
is dependent on activation of extracellular signal-regulated
kinase (ERK) 1/2 and c-Jun NH2-terminal kinase (JNK), but not
p38 [10]. Both large-VT ventilation and hyperoxia alone can
lead to the production of inflammatory cytokines, including
tumor necrosis factor-alpha, interleukin (IL)-1β, and murine
macrophage inflammatory protein-2 (MIP-2), a functional
homolog of human IL-8 in rodents [7,12,14,15].
The effects of hyperoxia on the lung have long been recog-
nized. Mice exposed to hyperoxia develop a condition similar
to ARDS, which is dependent on an increased production of
reactive oxygen species by mitochondria [13,16]. Hyperoxia
has been shown to cause alveolar hyaline membrane forma-
tion, edema, hyperplasia, proliferation of type II alveolar epithe-
lial cells, destruction of type I alveolar epithelial cells, interstitial
fibrosis, and pulmonary vascular remodeling [7]. Hyperoxia
has been shown to include activation of all three major
mitogen-activated protein kinase (MAPK) pathways – ERK1/2,
JNK, and p38 – in various experimental models [6,8,17]. In
previous studies, hyperoxia significantly exacerbated large-VT
VILI but the interaction between them was unclear [3,7,9]. We
hypothesized that the addition of hyperoxia to large-VT ventila-
tion would increase MIP-2 production, neutrophil infiltration,
and apoptosis via the MAPK pathways.
Materials and methods
Experimental animals
Male C57BL/6 mice (wild-type JNK+/+, JNK1-/-, or JNK2-/- on a
C57BL/6 background) weighing between 20 and 25 g were
obtained from The Jackson Laboratory (Bar Harbor, ME, USA)
and the National Laboratory Animal Center (Taipei, Taiwan)
[18,19]. JNK knockout mice develop normally, have no known
abnormal pathology, are fertile, are of normal size, and have
normal lung parenchyma and airways [20]. This study was per-
formed in accordance with animal experimental guidelines of
the National Institutes of Health (NIH) (Bethesda, MD, USA)
and with approval of the local research committee.
Ventilator protocol
We used our established mouse model of VILI as previously
described [20]. In brief, mice were ventilated with 30 ml/kg at
65 breaths per minute for one and five hours while breathing
room air or hyperoxia (> 95% oxygen). Oxygen was fed into
the inspiratory port of the ventilator when needed. Spontane-
ously breathing animals were exposed to hyperoxia in an
enclosed chamber as previously described [7]. Our previous
work has shown that activation of MAPK and increased mRNA
expression occurred approximately one hour after cell stretch,
whereas changes in cytokine production and neutrophil infil-
tration occur later. One hour of high-VT ventilation was used to
collect samples of total RNA and protein for Western blot anal-
ysis of MAPKs, and five hours of ventilation was used for col-
lection of samples of MIP-2, myeloperoxidase (MPO), Evans
blue dye (EBD) leak [20], and apoptotic and immunohisto-
chemical analyses. At the end of the study period, heparinized
blood was taken from the arterial line for analysis of arterial
blood gas and the mice were sacrificed. After sacrifice, the
lungs were lavaged three times with 0.6 ml of 0.9% normal
saline. The effluents were pooled and centrifuged at 2,000
rpm for 10 minutes. Supernatants were frozen at -80°C for fur-
ther analysis of cytokine. For histopathology, the lungs were
removed en bloc, and polyethylene tubing was inserted into
the trachea. The lungs were filled with 10% neutral buffered
formalin (pH 6.8 to 7.2) at a pressure of 30 cm H2O and
stored in formalin. For measurement of kinase activation, the
lungs were homogenized in 3 ml of lysis buffer (20 mM HEPES
[pH 7.4], 1% Triton X-100, 10% glycerol, 2 mM ethylene gly-
col-bis [β-aminoethyl ether]-N,N,N',N'-tetraacetic acid, 50 μM
β-glycerophosphate, 1 mM sodium orthovanadate, 1 mM dithi-
otreitol, 400 μM aprotinin, and 400 μM phenylmethylsulfonyl
fluoride), transferred to Eppendorf tubes, and placed on ice for
15 minutes. Tubes were centrifuged at 14,000 rpm for 10 min-
utes at 4°C, and supernatant was flash-frozen. For isolation of
total RNA, the lungs were homogenized in 1.5 ml of TRIzol rea-
gent and isolated according to the manufacturer's directions
(Invitrogen Corporation, Carlsbad, CA, USA) and flash-frozen.
The experimental design of this study is summarized in Table
1.
EBD analysis
Extravasation of EBD (Sigma-Aldrich, St. Louis, MO, USA) into
the interstitium was used as a quantitative measure of changes
of microvascular permeability in acute lung injury [20]. Thirty
minutes before the end of mechanical ventilation, 30 mg/kg of
EBD was injected through the internal jugular vein. At the time
of sacrifice (after five hours of mechanical ventilation), the
lungs were perfused free of blood by means of 1 ml of 0.9%
normal saline via the right ventricle and removed en bloc. EBD
was extracted from lung tissue after homogenization for two
minutes in 5 ml of formamide (Sigma-Aldrich) and incubated at
37°C overnight. The supernatant was separated by centrifuga-
tion at 5,000 g for 30 minutes, and the amount was recorded.
EBD in the plasma and lung tissue was quantitated by dual-
wavelength spectrophotometric analysis at 620 and 740 nm.
The method corrects the specimen's absorbance at 620 nm
for the absorbance of contaminating heme pigments by means
of the following formula: corrected absorbance at 620 =
actual absorbance at 620 nm - (1.426 [absorbance at 740
nm] + 0.03). We calculated the EBD amount extracted from
lung tissue and divided the amount by the weight of the lung
tissue.
Measurement of MIP-2
MIP-2 (1 pg/ml) was measured in bronchoalveolar lavage
(BAL) fluid by means of a commercially available immunoassay
kit containing antibodies that were cross-reactive with rat and
mouse MIP-2 (Biosource International, Camarillo, CA, USA).
Each sample was run in duplicate according to the manufac-
turer's instructions.Available online http://ccforum.com/content/11/1/R25
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MPO assay
The lungs (0.12 to 0.17 g) were homogenized in 5 ml of phos-
phate buffer (20 mM, pH 7.4). One milliliter of the homogenate
was centrifuged at 10,000 g for 10 minutes at 4°C. The result-
ing pellet was resuspended in 1 ml of phosphate buffer (50
mM, pH 6.0) containing 0.5% hexadecyltrimethylammonium
bromide. The suspension was then subjected to three cycles
of freezing (on dry ice) and thawing (at room temperature),
after which it was sonicated for 40 seconds and centrifuged
again at 10,000 g for 5 minutes at 4°C. The supernatant was
assayed for MPO activity by measuring the hydrogen peroxide
(H2O2)-dependent oxidation of 3,3', 5,5'-tetramethylbenzidine
(TMB). In its oxidized form, TMB has a blue color, which was
measured spectrophotometrically at 650 nm. The reaction
mixture for analysis consisted of 25 μl of tissue sample, 25 μl
of TMB (final concentration 0.16 mM) dissolved in dimethylsul-
foxide, and 200 μl of H2O2 (final concentration 0.30 mM) dis-
solved in phosphate buffer (0.08 M, pH 5.4) minutes prior to
being added to the mixture. The reaction mixture was incu-
bated for 3 minutes at 37°C, and the reaction was stopped by
adding 1 ml of sodium acetate (0.2 M, pH 3.0), after which
absorbance at 650 nm was measured. The absorbance
(A650) was reported in units of optical density per gram of wet
lung weight.
Extraction of nuclear proteins and electrophoretic 
mobility shift assay
The lungs (0.12 to 0.17 g) were homogenized and extraction
of nuclear protein was performed as previously described
[21]. Electrophoretic mobility shift assay (EMSA) was per-
formed with a digoxigenin (DIG) Gel Shift Kit according to
instructions of the manufacturer (Roche Diagnostics GmbH,
Mannheim, Germany). Briefly, nucleoproteins (10 μg) were
incubated with DIG-labeling probe in a 10-μl reaction mixture
containing 1× labeling buffer, 5 mM CoCl2, 0.05 mM DIG-
ddUTP, and 20 U/μl terminal transferase. The oligonucleotide
sequences were as follows: activator protein-1 (AP-1) oligonu-
cleotide (5'-d [C GCTTGATGAGTCAG-CCGGAA]-3') and
nuclear factor-kappa-B (NF-κB) oligonucleotide (5'-AGTT-
GAGGGGACTTTCCCAGG-3') (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA). To complete the specific binding
reactions, each of the 100-fold molar excesses of unlabeled
Table 1
Experimental design and numbers of animals per group
Control
(WT, JNK KO)
Control + O2
(WT, JNK KO)
VT of 30 ml/kg VT of 30 ml/kg
+ O2
VT of 30 ml/kg
+ JNK1 KO
VT of 30 ml/kg
+ JNK1 KO + 
O2
VT of 30 ml/kg
+ ERK inhibitor
VT of 30 ml/kg
+ ERK inhibitor 
+ O2
MPO, MIP-2
(5 hours of 
ventilation)
55555555
JNK, p38, ERK
(1 hour of 
ventilation)
55555555
PARP
(1, 2, and 5 
hours of 
ventilation)
55555555
MIP-2 mRNA
(1 hour of 
ventilation)
55555555
EBD assay
(5 hours of 
ventilation)
55555555
AP-1, NF-κB
(1 hour of 
ventilation)
55555555
IHC assay
(5 hours of 
ventilation)
55555555
TUNEL assay
(5 hours of 
ventilation)
5555
Electron 
microscopy
2222
AP-1 and NF-κB binding; total expression and phosphorylated forms of JNK, p38, and ERK1/2; PARP; IHC; and MIP-2 mRNA expression were 
measured in lung tissue. Time points for measurements were determined according to our previous findings that mediator activation occurs early 
in ventilator-induced lung injury and neutrophil infiltration occurs later [20]. AP-1, activator protein-1; Control, spontaneously breathing, non-
ventilated mice; EBD, Evans blue dye (a measurement of microvascular leak in the lung); ERK, extracellular signal-regulated kinase; IHC, 
immunohistochemical stain; JNK, c-Jun NH2-terminal kinase; KO, knockout; MIP-2, macrophage inflammatory protein-2 (a functional homolog of 
IL-8); MPO, myeloperoxidase (a measurement of total neutrophil infiltration in the lung); NF-κB, nuclear factor-kappa-B; O2, hyperoxia; PARP, poly 
(ADP-ribose) polymerase; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling, a measurement of apoptotic 
cells in the lung; VT, tidal volume; WT, wild-type.Critical Care    Vol 11 No 1    Li et al.
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oligonucleotides (negative control) was added to the binding
mixture before addition of the labeled probe. Nucleoprotein
complexes were resolved on an 8% non-denaturing polyacry-
lamide gel and were electrotransferred to nylon membrane
(Amersham Pharmacia Biotech, now part of GE Healthcare,
Little Chalfont, Buckinghamshire, UK). Blots were blocked
with 1% dried milk in maleic acid buffer and incubated with
anti-DIG-alkaline phosphatase (1:10,000). Blots were devel-
oped by 3-(4-methoxyspiro{1,2-dioxetane-3,2'-(5'-chloro)tricy-
clo [3.3.1.13,7] decan}-4-yl)phenyl phosphate and exposed to
Kodak XAP-5 film (Eastman Kodak, Rochester, NY, USA) at
room temperature.
Immunoblot analysis
Crude cell lysates were matched for protein concentration,
resolved on a 10% bis-acrylamide gel, and electrotransferred
to Immobilon-P membranes (Millipore Corporation, Billerica,
MA, USA). For assay of total JNK, p38, and ERK1/2 phospho-
rylation protein expression, Western blot analyses were per-
formed with antibodies to phospho-JNK, phospho-p38, and
phospho-ERK1/2 (New England Biolabs, Inc., Ipswich, MA,
USA). For determination of total JNK, p38, ERK1/2 protein
expression, Western blot analyses were performed with the
respective antibodies (Santa Cruz Biotechnology, Inc.). Blots
were developed by enhanced chemiluminescence (NEN Life
Science Products, now part of PerkinElmer Life and Analytical
Sciences, Inc., Waltham, USA).
Immunohistochemistry
The lung tissues from control, non-ventilated mice exposed to
high-VT ventilation for five hours while breathing room air or
hyperoxia were paraffin-embedded, sliced at 4 μm, deparaffin-
ized, antigen-unmasked in 10 mM sodium citrate (pH 6.0), and
incubated with phospho-JNK, phospho-ERK1/2, or poly(ADP-
ribose)polymerase (PARP) primary antibody (1:100; New
England Biolabs, Inc.) and biotinylated goat anti-rabbit sec-
ondary antibody (1:100) according to the instructions of an
immunohistochemical kit (Santa Cruz Biotechnology, Inc.).
The specimens were further conjugated with horseradish per-
oxidase-streptoavidin complex, detected by diaminobenzidine
(DAB) substrate mixture, and counterstained by hematoxylin. A
dark brown DAB signal indicated positive staining of MAPKs
of epithelial cells, and shades of light blue signified non-reac-
tive cells.
Electron microscopy assay
The lungs were filled with 3% glutaraldehyde in 0.1 M
cacodylate buffer (pH 7.4) at a pressure of 30 cm H2O and
fixed in the same glutaraldehyde buffer for one hour at 4°C.
The lung tissues were then postfixed in 1% osmium tetroxide
(pH 7.4), dehydrated in a graded series of ethanol, and
embedded in EPON-812. Thin sections (70 nm) were cut,
stained with uranyl acetate and lead citrate, and examined on
a Hitachi H-7500 EM transmission electron microscope
(Hitachi, Ltd., Tokyo, Japan).
Pharmacologic inhibitor
ERK1/2 inhibitor (PD-98059; Calbiochem, San Diego, CA,
USA), which has been shown to be useful in elucidating the
role of ERK [22], was given subcutaneously (1 mg/kg) 30 min-
utes before ventilation. The dose was based on previous in
vivo studies that showed that 1 mg/kg inhibited ERK1/2 activ-
ity [23].
Statistical evaluation
The MIP-2 mRNA, EMSA, and Western blots were quantitated
using an NIH image analyzer ImageJ 1.27z (NIH) and pre-
sented as the ratio of phospho-MAPK to MAPK (relative phos-
phorylation) in arbitrary units. Values were expressed as the
mean ± standard error of the mean for at least five experi-
ments. The data of neutrophils, MIP-2, MPO, EBD, terminal
deoxynucleotidyl transferase-mediated dUTP-biotin nick end-
labeling (TUNEL) analysis, and immunohistochemical analysis
were analyzed using Statview 5.0 Abascus Concepts Inc.,
Cary, NC, USA, and SAS Institute Inc., Cary, NC, USA). All
results of Western blot, EMSA, and MPO were normalized to
control, non-ventilated mice breathing room air. Analysis of
variance was used to assess the statistical significance of the
differences, followed by multiple comparisons with a Scheffe's
test, and a p value of less than 0.05 was considered statisti-
cally significant. Additional details, including the experimental
design and the number of animals used in each group, RNase
protection assay, and TUNEL assay, were the same as those
previously described [17].
Results
Physiologic data
As we previously published [20], there were no statistical dif-
ferences in pH, PaCO2 (arterial carbon dioxide tension), or
mean arterial pressure from the beginning to the end of
mechanical ventilation. Inhibition of JNK activation with JNK1
knockout mice reduced the effects of hyperoxia on high-VT-
induced infiltration of neutrophils, cytokine production, and
microvascular permeability.
To determine the effects of hyperoxia on neutrophil content in
the vasculature, lung parenchyma, and alveoli, we measured
MPO activity (Figure 1a). The MPO levels in mice ventilated
with hyperoxia at a VT of 30 ml/kg were significantly elevated
compared with control, non-ventilated mice and mice venti-
lated with room air at a VT of 30 ml/kg. By using JNK1-/- knock-
out mice receiving room air or hyperoxia with high-VT (30 ml/
kg) mechanical ventilation, we found significantly decreased
levels of MPO in JNK knockout mice.
To determine whether the increased neutrophil sequestration
with hyperoxia in high-VT mechanical ventilation was associ-
ated with upregulation of chemotactic factors for neutrophils
and increased AP-1 DNA binding, we measured MIP-2 mRNA
expression, AP-1-binding activity, and MIP-2 protein produc-
tion for one and five hours of mechanical ventilation, respec-Available online http://ccforum.com/content/11/1/R25
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tively (Figures 1b and 2a). We used EBD to measure
microvascular permeability (Figure 1c). We found that hyper-
oxia increased ventilator-induced MIP-2 mRNA expression,
AP-1 DNA-binding activity, MIP-2 protein production, and
EBD leak in the mice ventilated at a VT of 30 ml/kg compared
with those of control, non-ventilated mice and mice ventilated
with room air at a VT of 30 ml/kg. The effects of hyperoxia on
high-VT  (30 ml/kg) ventilator-induced expression of MIP-2
mRNA, AP-1-binding activity, production of MIP-2 protein, and
EBD leak were significantly reduced via homozygous disrup-
tion of the JNK1 or JNK2 locus (data not shown). In a previous
study, we found similar reductions in MPO and MIP-2 in JNK1
and JNK2 knockout mice, suggesting that sequential activa-
tion of JNK1 and JNK2 may be needed for activation of the
pathway [20]. The NF-κB-binding activity was also increased,
but there were no significant differences between the mice
ventilated with room air and hyperoxia (Figure 2b). This sug-
gested that addition of oxygen may be involved in high-VT-
induced MIP-2 production and that MIP-2 production was
dependent, in part, on the JNK/AP-1 pathway.
To further define the effects of hyperoxia on MAPK activation
in VILI, we measured the activity of three members of the
MAPK families – JNKs, p38, and ERK1/2 – in mice exposed to
high-VT (30 ml/kg) mechanical ventilation for one hour while
breathing room air or hyperoxia. Hyperoxia increased the high-
VT-induced phosphorylation of JNKs and ERK1/2 but did not
change the expression of total non-phosphorylated proteins of
JNKs and ERK1/2 (Figure 3a,c). Both JNK1 and JNK2 phos-
phorylation decreased in JNK1 knockout mice. JNK1 knockout
mice have an intact JNK2 gene. However, each gene was
capable of making the various isoforms of JNK via alternate
splicing [20], and this may have led to a compensatory
decrease in JNK2 expression.
The effects of hyperoxia were significantly reduced in
homozygous JNK knockout mice ventilated at a VT of 30 ml/kg.
The phosphorylation of p38 was also increased, but there was
no significant difference between high-VT-ventilated mice with
or without hyperoxia in wild-type or JNK knockout mice (Figure
3b). Using immunohistochemistry, we confirmed the results of
Western blot (Figure 3). Hyperoxia increased positive staining
of phospho-JNK in airway epithelium of mice ventilated at a VT
of 30 ml/kg for five hours (Figures 4 and 5). The increases of
positive staining of phospho-JNK on airway epithelium were
reduced in homozygous JNK knockout mice. Due to poor
breeding performance of homozygous JNK2-/- mice, only a few
experiments were carried out with this strain and these exper-
iments showed a trend similar to that of JNK1-/- mice (data not
shown). These data added further evidence that hyperoxia-
augmented lung stretch-induced lung inflammation was
dependent, in part, on the JNK pathway, but the role of ERK
activation needed to be further explored. Inhibition of ERK1/2
activation with PD98059 reduced the effects of hyperoxia on
Figure 1
Effects of hyperoxia on stretch-induced neutrophil infiltration, macro- phage inflammatory protein-2 (MIP-2) production, and microvascular  leak in JNK knockout mice Effects of hyperoxia on stretch-induced neutrophil infiltration, macro-
phage inflammatory protein-2 (MIP-2) production, and microvascular 
leak in JNK knockout mice. (a) Myeloperoxidase (MPO) assay of lung 
tissue from control, non-ventilated mice, and mice ventilated for five 
hours at a tidal volume (VT) of 30 ml/kg with room air (RA) or hyperoxia 
(n = 5 per group). (b) MIP-2 production in bronchoalveolar lavage 
(BAL) fluid from control, non-ventilated mice, and mice ventilated for 
five hours at a VT of 30 ml/kg with RA or hyperoxia (n = 5 per group). 
(c) Evans blue dye (EBD) analysis of lung tissue from control, non-ven-
tilated mice, and mice ventilated for five hours at a VT of 30 ml/kg with 
RA or hyperoxia (n = 5 per group). *p < 0.05 versus control, non-venti-
lated mice; †p < 0.05 versus all other groups. JNK, c-Jun NH2-terminal 
kinase; OD, optical density; WT, wild-type.Critical Care    Vol 11 No 1    Li et al.
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Figure 2
Effects of hyperoxia on stretch-induced macrophage inflammatory protein-2 (MIP-2) mRNA expression and DNA binding in JNK knockout mice Effects of hyperoxia on stretch-induced macrophage inflammatory protein-2 (MIP-2) mRNA expression and DNA binding in JNK knockout mice. (a) 
MIP-2 mRNA (top panel), GAPDH mRNA (middle panel), and arbitrary units (bottom panel) from control, non-ventilated mice, and mice ventilated at 
a tidal volume (VT) 30 ml/kg for one hour with room air (RA) or hyperoxia (n = 5 per group). The ratio of MIP-2 mRNA to GAPDH was expressed in 
arbitrary units. The expression of MIP-2 mRNA was performed by RNase protection assay. (b) Nuclear proteins of lung tissue from control, non-ven-
tilated mice, and mice ventilated at a VT of 30 ml/kg without or with hyperoxia were incubated with or without excess unlabeled activator protein-1 
(AP-1) or nuclear factor-kappa-B (NF-κB) consensus oligonucleotide (negative control) (n = 5 per group). Arbitrary units were expressed as 
increase of DNA-binding activity as described in Materials and methods. *p < 0.05 versus control, non-ventilated mice; †p < 0.05 versus all other 
groups. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; JNK, c-Jun NH2-terminal kinase; NC, control, non-ventilated mice; O2, mice with 
hyperoxia; WT, wild-type.
A Control VT 30 ml
WT JNK1-/-
RA O2 RA O2 RA O2
MIP-2 mRNA
GAPDH
Arbitrary Units 1.1r0.1 1r0.1 2.5r0.2
*6.8r0.4
*1r0.1 1.4r0.2
*
B
NC Control VT 30 ml
WT JNK1-/-
RA O2 RA O2 RA O2
AP-1
Arbitrary Units 0 1r0.1 1.1r0.2 2.9r1
*3.6r1
*1.7r1
* 1.4r0.3
*
NF-NB
Arbitrary Units 0 1.1r0.1 1r0.1 2.5r1
*2.4r1
* 2.3r1
* 2.2r1
*Available online http://ccforum.com/content/11/1/R25
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Figure 3
Effects of hyperoxia on high-tidal volume (VT)-induced mitogen-activated protein kinase activation Effects of hyperoxia on high-tidal volume (VT)-induced mitogen-activated protein kinase activation. (a) Phosphorylated JNK expression (top panel), 
total JNK protein expression (middle panel), and quantitation by arbitrary units (bottom panel) (n = 5 per group). (b) Phosphorylated p38 expression 
(top panel), total p38 protein expression (middle panel), and quantitation by arbitrary units (bottom panel) (n = 5 per group). (c) Phosphorylated 
ERK1/2 expression (top panel), total ERK1/2 protein expression (middle panel), and quantitation by arbitrary units (bottom panel) (n = 5 per group). 
The relative phosphorylation was expressed in arbitrary units. *p < 0.05 versus control, non-ventilated mice; †p < 0.05 versus all other groups. ERK, 
extracellular signal-regulated kinase; JNK, c-Jun NH2-terminal kinase; O2, mice with hyperoxia; RA, mice with room air; WT, wild-type C57BL/6 mice.
A Control VT 30 ml
WT JNK1-/-
RA O2 RA O2 RA O2
Phospho-JNK
JNKs
Relative Phosphorylation 1r0.1 1r0.2 2.1r0.1
*3.5r0.5
*1.5r0.3
* 1.7r0.4
*
B
Control VT 30 ml
WT JNK1-/-
RA O2 RA O2 RA O2
Phospho-p38
P38
Relative Phosphorylation 1r0.2 1r0.1 1.3r0.3
* 1.4r0.2
*1.5r0.2
* 1.6r0.1
*
C
Control VT 30 ml
WT JNK1-/-
RA O2 RA O2 RA O2
Phospho-ERK1/2
ERK1/2
Relative Phosphorylation 1r0.3 0.9r0.1 1.6r0.4
* 2.5r0.3
*1.8±0.4
*
2.0±0.3
*
54kDa
46kDa
54kDa
46kDa
38kDa
38kDa
44kDa
42kDa
44kDa
42kDaCritical Care    Vol 11 No 1    Li et al.
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high-VT-induced infiltration of neutrophils, MIP-2 protein pro-
duction, and microvascular permeability.
To determine the role of ERK1/2 activation on the effects of
hyperoxia in VILI, we measured the activity of ERK1/2 in mice
pretreated with PD98059 and exposed to high-VT (30 ml/kg)
mechanical ventilation for one hour while breathing room air or
hyperoxia (Figure 6). There was a significant inhibition of
ERK1/2 phosphorylation but no change in the expression of
total non-phosphorylated ERK1/2 protein in mice with room air
and hyperoxia (> 95% oxygen). ERK1 and ERK2 were
affected equally. Using immunohistochemistry (Figure 6b), we
confirmed the results of Western blot (Figure 6a). Hyperoxia
increased the positive staining of phospho-ERK1/2 in airway
epithelium of mice ventilated at a VT of 30 ml/kg for five hours.
The increases of positive staining of phospho-ERK1/2 on air-
way epithelium were reduced via pharmacologic inhibition with
PD98059. This confirmed that the PD98059 successfully
inhibited ERK activation in high-VT ventilation both with and
without hyperoxia.
To determine the role of ERK1/2 activation in ventilator-
induced neutrophil sequestration and upregulation of chemo-
tactic factor with hyperoxia, we pretreated mice with specific
ERK1/2 inhibitor (PD98059) for 30 minutes (Figure 7a,b). The
increased MPO levels and the MIP-2 protein production were
significantly reduced by using PD98059 in mice ventilated
with hyperoxia at a VT of 30 ml/kg for five hours but not in mice
ventilated with room air at a VT of 30 ml/kg. This suggested
that the ERK1/2 pathway also contributed to neutrophil
accumulation chemoattracted by MIP-2 in VILI during hyper-
oxia. Microvascular permeability, as measured by EBD, was
significantly reduced by using PD98059 (Figure 7c).
Hyperoxia increased lung stretch-induced apoptosis
We performed an apoptosis assay (TUNEL stain and electron
microscopy) to determine the effects of hyperoxia on high-VT
ventilation-induced apoptosis of airway epithelium. Apoptosis
of alveolar epithelia was increased in mice with high-VT (30 ml/
kg) mechanical ventilation for five hours while breathing room
air (Figure 8b) or greater than 95% oxygen (hyperoxia) (Figure
8c) as compared with control, non-ventilated mice (Figure 8a).
Apoptosis was further confirmed by electron micrographs that
showed the characteristic nuclear condensation of bronchial
epithelium in mice ventilated with high VT values while breath-
ing room or greater than 95% oxygen (Figure 8e,f). This
suggested that high-VT ventilation with room air or hyperoxia
can induce lung injury by an apoptotic process.
Figure 4
Effects of hyperoxia on stretch-induced JNK activation of airway epithe- lium in JNK knockout mice Effects of hyperoxia on stretch-induced JNK activation of airway epithe-
lium in JNK knockout mice. Representative photomicrographs (×400) 
with phospho-JNK staining of the lung sections after five hours of 
mechanical ventilation with room air or hyperoxia (n = 5 per group). (a) 
Control wild-type mice with room air. (b) Control wild-type mice with 
hyperoxia. (c) Wild-type mice ventilated at a tidal volume (VT) of 30 ml/
kg with room air. (d) Wild-type mice ventilated at a VT of 30 ml/kg with 
hyperoxia. (e) JNK1-/- mice ventilated at a VT of 30 ml/kg with room air. 
(f) JNK1-/- mice ventilated at a VT of 30 ml/kg with hyperoxia. Positive 
staining of airway epithelia is identified by arrows. A dark brown DAB 
signal indicates positive staining for JNK in the lung epithelium, and 
shades of bluish tan signify non-reactive cells. DAB, diaminobenzidine; 
JNK, c-Jun NH2-terminal kinase.
Figure 5
Effects of hyperoxia on stretch-induced JNK activation of airway epithe- lium in JNK knockout mice Effects of hyperoxia on stretch-induced JNK activation of airway epithe-
lium in JNK knockout mice. Phospho-JNK-positive cells were quantified 
as the average number of epithelial cells with dark brown DAB signals 
per bronchiole, which were counted from 10 randomly chosen bronchi-
oles of each section (n = 5 per group). *p < 0.05 versus control, non-
ventilated mice; †p < 0.05 versus all other groups. DAB, diaminobenzi-
dine; JNK, c-Jun NH2-terminal kinase; RA, room air; VT, tidal volume; 
WT, wild-type mice.
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Figure 6
PD98059 reduced the effects of hyperoxia on high-tidal volume (VT)-induced ERK1/2 activation PD98059 reduced the effects of hyperoxia on high-tidal volume (VT)-induced ERK1/2 activation. The mice ventilated at a VT of 30 ml/kg (VT 30 ml) 
with or without hyperoxia were pretreated with 1 mg/kg PD98059 for 30 minutes. (a) Phosphorylated ERK1/2 expression (top panel), total ERK1/2 
protein expression (middle panel), and quantitation by arbitrary units (bottom panel) (n = 5 per group). The relative phosphorylation was expressed in 
arbitrary units. (b) Representative photomicrographs (×400) with phospho-ERK1/2 staining of the lung sections (n = 5 per group). (A) Control wild-
type mice with room air. (B) Control wild-type mice with hyperoxia. (C) Wild-type mice ventilated at a VT of 30 ml/kg with room air. (D) Wild-type 
mice ventilated at a VT of 30 ml/kg with hyperoxia. (E) Mice pretreated with PD98059 and ventilated at a VT of 30 ml/kg with room air. Positive stain-
ing of airway epithelia is identified by arrows. (F) Mice pretreated with PD98059 and ventilated at a VT of 30 ml/kg with hyperoxia. Phospho-ERK1/
2-positive cells were quantified as the average number of epithelial cells with dark brown DAB signals per bronchiole, which were counted from 10 
randomly chosen bronchioles of each section (n = 5 per group). *p < 0.05 versus control, non-ventilated mice; †p < 0.05 versus all other groups. 
DAB, diaminobenzidine; ERK, extracellular signal-regulated kinase; O2, mice with hyperoxia; RA, mice with room air; WT, wild-type mice.Critical Care    Vol 11 No 1    Li et al.
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Inhibition of JNK or ERK reduced the effects of hyperoxia 
on high-VT-induced apoptosis
To determine the roles of JNK and ERK1/2 activation in venti-
lator-induced epithelial apoptosis, we used homozygous JNK1
knockout mice and wild-type mice treated with the ERK1/2
inhibitor PD98059. To confirm programmed cell death by
another method and to quantify the amount of apoptotic cells,
we used the cleaved PARP antibody (89 kDa), a hallmark of
apoptosis. The increased apoptosis, as measured by cleaved
PARP activity, was reduced in JNK1 knockout mice and
ERK1/2 activation with ERK1/2 inhibitor (PD98059) (Figure
9). This suggested that epithelial apoptosis induced by high-
VT ventilation with room air or hyperoxia was dependent on the
JNK and ERK pathways.
Discussion
We used hyperoxia as an oxidant stress model of VILI because
it is commonly used in patients with ARDS. In this mouse
model of VILI, we found that hyperoxia increased high-VT-
induced neutrophil infiltration, MIP-2 protein production,
microvascular permeability, and apoptosis in lung epithelial
cells. Activation of the JNK pathway was involved in ventilator-
induced neutrophil infiltration, cytokine production, and
microvascular permeability with and without hyperoxia (Fig-
ures 1, 2, 3, 4, 5 and 9). Both ERK and JNK were involved in
airway epithelial cell apoptosis with and without hyperoxia.
However, ERK1/2 activation was involved in increased MIP-2
production and neutrophil infiltration only in mice exposed to
high-VT ventilation with hyperoxia (Figures 3c, 6, 7, and 9). The
differences in the activation of signaling pathways with lung
stretch by mechanical ventilation with and without hyperoxia
are depicted in Figure 10.
High-VT ventilation using hyperoxia has been shown in rat
models to induce neutrophil migration into the alveoli and was
dependent on the production of MIP-2, a chemoattractant
belonging to the CXC family of cytokines [7,24]. Hyperoxia
alone had minimal effects on both IL-8 and MIP-2 production
[1,7]. In a previous study, we found that the addition of oxygen
to rats ventilated at a VT of 20 ml/kg markedly increased the
BAL content of neutrophils [7]. We also showed that
hyperoxia increased high-VT-induced neutrophil sequestration
and MIP-2 production (Figure 1) in the present study, but we
went on to examine the pathways involved.
Hyperoxia may induce all three major MAPK (JNK, p38, and
ERK1/2) pathways and transcription factors (AP-1 and NF-
κB) in various in vivo (C57BL/6 mice) and in vitro (human
A549 and mouse MLE-12 alveolar epithelial cells) experimen-
tal models [4,6,8,16,25-27]. Hyperoxia-induced lung injury
has been found to be mediated by JNK, p38, and AP-1 path-
ways and may induce factors that inhibit downstream apop-
totic events without significant phosphatidylserine
translocation [6,8]. We found that hyperoxia increased high-
VT-induced JNK activation, DNA-binding activity of AP-1, and
Figure 7
PD98059 reduced the effects of hyperoxia on stretch-induced neu- trophil infiltration, macrophage inflammatory protein-2 (MIP-2) produc- tion, and microvascular leak PD98059 reduced the effects of hyperoxia on stretch-induced neu-
trophil infiltration, macrophage inflammatory protein-2 (MIP-2) produc-
tion, and microvascular leak. The mice ventilated at a tidal volume (VT) 
of 30 ml/kg (VT 30 ml) with and without hyperoxia were pretreated with 
1 mg/kg PD98059 for 30 minutes. (a) Myeloperoxidase (MPO) assay 
of lung tissue (n = 5 per group). (b) MIP-2 production in bronchoalveo-
lar lavage (BAL) fluid (n = 5 per group). (c) Evans blue dye (EBD) anal-
ysis of lung tissue (n = 5 per group). *p < 0.05 versus control, non-
ventilated mice; †p < 0.05 versus all other groups. ERK, extracellular 
signal-regulated kinase; OD, optical density; RA, room air.Available online http://ccforum.com/content/11/1/R25
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MIP-2 mRNA expression after one hour of high-VT ventilation
(Figures 2a, 2b, and 3a) and that these increases were even
more elevated after five hours of ventilation (data not shown).
We have previously shown a sustained increase in JNK activa-
tion over the span of five hours of ventilation in normoxia [2].
Others have shown that JNK1-/- mice, after exposure to hyper-
oxia for 65 hours, have increased susceptibility to hyperoxia-
induced epithelial cell apoptosis [16]. It is believed that tran-
sient activation of the JNK pathway by hyperoxia is protective,
whereas prolonged exposure led to sustained JNK-mediated
transcription of genes that are involved in apoptotic cell death
[28,29]. For p38 phosphorylation, we found no significant dif-
ference between high-VT-ventilated mice with or without
hyperoxia (Figure 3b). The p38 MAPK pathway may have con-
tributed to post-transcriptional induction of IL-8 synthesis by
stabilizing its mRNA via MAPK-activated protein kinase 2 and
an AU-rich region [30], but this has not been explored in VILI.
Others have shown that ERK1/2, in addition to its involvement
in the protective action of growth factors against cell death,
played important roles as an upstream regulator of induced
inflammatory mediators in response to stress and that inhibi-
tion of ERK1/2 reduced increases in lung injury parameters
and neutrophil influx into the lungs [31]. Using rat and isolated
mouse lung models, Uhlig and colleagues [10] found that the
ERK pathway did not significantly contribute to the ventilator-
induced releases of MIP-2 in spite of the increased expression
of phopho-ERK1/2. In our study, inhibition of ERK1/2 with
PD98059 (Figure 7) also did not affect high-VT-induced MIP-
2 production or neutrophil sequestration while the mice were
breathing room air. However, the increased neutrophil seques-
Figure 8
Apoptosis of airway epithelium during high-tidal volume (VT) ventilation with or without hyperoxia Apoptosis of airway epithelium during high-tidal volume (VT) ventilation with or without hyperoxia. Representative photomicrographs (×400) with 
TUNEL staining (a-c) (n = 5 per group) and electron micrographs (d-f) (n = 2 per group) of the lung sections after five hours of high-VT (30 ml/kg) 
mechanical ventilation without or with hyperoxia. (a,d) Control non-ventilated wild-type mice. (b,e) Wild-type mice ventilated at a VT of 30 ml/kg with 
room air. (c,f) Wild-type mice ventilated at a VT of 30 ml/kg with hyperoxia. Apoptotic cells are identified by asterisks or arrows. A dark brown DAB 
signal indicates positive staining of apoptotic cells, and shades of blue-green to greenish tan signify non-reactive cells. Highly condensed and frag-
mented heterochromatin of bronchial epithelial cells indicates apoptosis. Scale bars = 20 μm (a-c), 4 μm (d-f). DAB, diaminobenzidine; TUNEL, ter-
minal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling.Critical Care    Vol 11 No 1    Li et al.
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tration and MIP-2 production with VILI plus hyperoxia were
reduced by PD98059. This suggested that JNK activation was
necessary for lung stretch-induced cytokine production, but
the augmentation of lung stretch-induced MIP-2 production by
hyperoxia required the activation of both ERK1/2 and JNK
pathways.
Previous studies have shown that hyperoxia may induce non-
apoptotic or apoptotic epithelial cell death, depending on the
species, cell-type specificities of hyperoxic insult, and culture
condition [1-9]. Using human A549 alveolar epithelial cells
and isolated mouse lung, others found that hyperoxia can
directly cause lung injury by generation of reactive oxygen spe-
cies and that mice exposed to hyperoxia will be more suscep-
tible to the deleterious effects of high-VT ventilation [1,3].
Barazzone and colleagues [17] exposed mice to 100% oxy-
gen for three or four days and found that both necrosis and
apoptosis were involved in the cell death during hyperoxia. In
our study, we found that high-VT ventilation with or without
hyperoxia increased chromatin condensation of type II epithe-
lia (characteristic of apoptosis) and damaged structures of the
cytoplasm as compared with those of non-ventilated mice,
JNK1-/- mice, and wild-type mice pretreated with ERK inhibitor
(Figure 8). Differentiating between apoptosis and necrosis can
be difficult. We confirmed apoptosis using electron micros-
copy, TUNEL staining, and staining for cleaved PARP, sug-
gesting that hyperoxia plus high-VT ventilation does induce cell
death, at least in part, through an apoptotic pathway. Using
Figure 9
JNK knockout and PD98059-treated mice reduced hyperoxia-aug- mented, high-tidal volume (VT)-induced apoptosis of airway epithelium JNK knockout and PD98059-treated mice reduced hyperoxia-aug-
mented, high-tidal volume (VT)-induced apoptosis of airway epithelium. 
The mice ventilated at a VT of 30 ml/kg with or without hyperoxia were 
pretreated with 1 mg/kg PD98059 for 30 minutes. Representative pho-
tomicrographs (×400) with cleaved PARP staining of the lung sections 
(n = 5 per group). (a) Control wild-type (WT) mice with room air (RA). 
(b) Control WT mice with hyperoxia. (c) WT mice ventilated at a VT of 
30 ml/kg with RA. (d) WT mice ventilated at a VT of 30 ml/kg with 
hyperoxia. (e) JNK1-/- mice ventilated at a VT of 30 ml/kg with RA. (f) 
JNK1-/- mice ventilated at a VT of 30 ml/kg with hyperoxia. (g) WT mice 
pretreated with PD98059 and ventilated at a VT of 30 ml/kg with RA. 
(h) WT mice pretreated with PD98059 and ventilated at a VT of 30 ml/
kg with hyperoxia. Positive staining of airway epithelia is identified by 
arrows. Cleaved PARP-positive cells were quantified as the average 
number of epithelial cells with dark brown DAB signals per bronchiole, 
which were counted from 10 randomly chosen bronchioles of each 
section (n = 5 per group). *p < 0.05 versus control, non-ventilated 
mice; †p < 0.05 versus ventilation in JNK1-/- or with PD98059. DAB, 
diaminobenzidine; ERK, extracellular signal-regulated kinase; JNK, c-
Jun NH2-terminal kinase; PARP, poly(ADP-ribose)polymerase.
Figure 10
Differences in signaling pathway activation with lung stretch with  mechanical ventilation with and without hyperoxia Differences in signaling pathway activation with lung stretch with 
mechanical ventilation with and without hyperoxia. Activation of the JNK 
pathway was involved in ventilator-induced neutrophil infiltration, 
cytokine production, and microvascular permeability with and without 
hyperoxia. Both ERK and JNK were involved in airway epithelial cell 
apoptosis with and without hyperoxia. The major difference in the sign-
aling pathway activation was that ERK1/2 activation was involved in 
increased MIP-2 production and neutrophil infiltration only in mice 
exposed to high-tidal volume ventilation with hyperoxia, and not in mice 
exposed to high-tidal volume ventilation without hyperoxia. JNK activa-
tion was involved with and without hyperoxia. ERK, extracellular signal-
regulated kinase; JNK, c-Jun NH2-terminal kinase; MIP-2, macrophage 
inflammatory protein-2.Available online http://ccforum.com/content/11/1/R25
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JNK1-/- mice and ERK inhibitor, we found that the apoptotic
cell death decreased, suggesting the involvement of JNK and
ERK in the apoptotic process of high-VT ventilation and hyper-
oxia (Figure 9).
ERK activation was involved in high-VT  ventilator-induced
apoptosis with and without hyperoxia but was involved in ven-
tilator-induced lung inflammation only with hyperoxia (Figures
7 and 9). This suggests that the use of ERK inhibition as a ther-
apeutic modality would be effective only in hyperoxia and not
with the use of normoxia, whereas JNK inhibition would be
effective no matter what the oxygen requirement were (Figure
10). We have previously shown that the pharmacological inhi-
bition of JNK protected mice from VILI [20].
DNA-binding activity of NF-κB has been shown to increase
after high-VT ventilation in ex vivo isolated mouse lung and in
vitro  human alveolar A549 epithelial cell studies [12,21].
Using normal human bronchial epithelial cells exposed to
hyperoxia for five days, others found that NF-κB protected
lung epithelial cells from hyperoxia-induced non-apoptotic cell
death via NF-κB-mediated IκBα synthesis and by maintaining
the levels of superoxide dismutase [4]. We found that DNA-
binding activity of NF-κB was also increased after high-VT ven-
tilation, but there were no significant effects of hyperoxia on its
activation (Figure 2b). This suggested that NF-κB played a
minor role in hyperoxia augmentation of VILI in comparison
with AP-1.
The effects of high-VT ventilation and hyperoxia occur in the
first few hours of VILI. In clinical practice after intubations,
patients are often ventilated initially with higher VT values and
100% oxygen. Our data suggested that this practice may
increase lung injury during the initial hours of ventilation.
Conclusion
Using an in vivo mouse model, we found that hyperoxia
increased high-VT-induced apoptotic and non-apoptotic epi-
thelial cell injury and resulted in increased lung neutrophil
sequestration and increased MIP-2 production, which were
dependent, at least in part, on the JNK and ERK pathways.
These data have added to the understanding of the effects of
mechanical forces in the lung. In patients with severe ARDS,
maintaining a low VT (6 ml/kg) and low levels of oxygen (FiO2
[fraction of inspired oxygen] of less than or equal to 0.5) is
sometimes not possible. The inhibition of JNK and ERK1/2
may offer new treatment options for these patients.
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